Podcast

Building the Case for Early Rheumatoid Arthritis Therapy

Podcast outlines the benefits of aggressive, early therapy and a patient-centered management approach for rheumatoid arthritis.

Part of the “No Patient Left Behind: Building the Case for Early RA Therapy” series of CME-accredited podcasts created by the Center for Independent Healthcare Education, this podcast discusses research related to early rheumatoid arthritis presented at the 2009 American College of Rheumatology Annual Scientific Meeting. The physician presenters “discuss the latest results from three clinical trials that compared the use of conventional DMARDs and biologics for the treatment of early RA.”

Click here to access and download this third-party podcast resource.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.